Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C A Seipp

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 1999
Impact of cytokine administration on the generation of antitumor reactivity in patients with metastatic melanoma receiving a peptide vaccineS A Rosenberg, J C Yang, D J Schwartzentruber, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 27, 2001
A prospective, randomized, double-blind, placebo-controlled trial evaluating the effect of nystatin on the development of oral irritation in patients receiving high-dose intravenous interleukin-2G A Ohnmacht, G Q Phan, S A Mavroukakis, et al.
Nature Medicine|March 21, 1998
Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanomaS A Rosenberg, J C Yang, D J Schwartzentruber, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 1999
Impact of cytokine administration on the generation of antitumor reactivity in patients with metastatic melanoma receiving a peptide vaccineS A Rosenberg, J C Yang, D J Schwartzentruber, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 27, 2001
A prospective, randomized, double-blind, placebo-controlled trial evaluating the effect of nystatin on the development of oral irritation in patients receiving high-dose intravenous interleukin-2G A Ohnmacht, G Q Phan, S A Mavroukakis, et al.
Nature Medicine|March 21, 1998
Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanomaS A Rosenberg, J C Yang, D J Schwartzentruber, et al.
Pageof 4